AURORA, Colo., Sept. 27, 2022 /PRNewswire/ — Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the company patent No.11,447,833 for the detection of minimal residual disease…
News
CHERIBUNDI ANNOUNCES NEW COLLECTIVE OF TEAM USA ATHLETES AS BRAND PARTNERS
Five Team USA Athletes, Headlined by Ryan Murphy, Chase Budinger and Delaney Schnell, Join Cheribundi’s Group of Elite Athlete Ambassadors Leading up to the 2024 Olympic Games BOULDER, Colo., July 24, 2024 /PRNewswire/ — Cheribundi, […]
News
Scientists Invent Model to Make Drug Dosing Safer for Babies
A new tool developed in a CU Anschutz lab may help clinicians make data-driven prescribing decisions for infants. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech […]
News
New Study Reveals Why Common Leukemia Treatments Fail in Some Patients
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn’t work for everyone. The findings could help doctors better match patients […]
